Skip to main content

In the Wake of Failed Alzheimer's Drug Trials, Scientists Are Cautiously Finding Hope With a New Strategy

"This drug goes after a different target than most of these high-profile trials."

from gizmodo http://www.gizmodo.co.uk/2019/03/in-the-wake-of-failed-alzheimers-drug-trials-scientists-are-cautiously-finding-hope-with-a-new-strategy/
Labels:

Comments

Post a Comment

Popular posts from this blog

Voices in AI – Bonus: A Conversation with Hilary Mason

[voices_in_ai_byline] About this Episode On this Episode of Voices in AI features Byron speaking with Hilary Mason, an acclaimed data and research scientist, about the mechanics and philosophy behind designing and building AI. Listen to this episode or read the full transcript at www.VoicesinAI.com Transcript Excerpt Byron Reese: This is Voices in AI, brought to you by Gigaom and I am Byron Reese. Today, our guest is Hilary Mason. She is the GM of Machine Learning at Cloudera, and the founder and CEO of Fast Forward Labs, and the Data Scientist in residence at Accel Partners, and a member of the Board of Directors at the Anita Borg Institute for Women in Technology, and the co-founder of hackNY.org. That’s as far down as it would let me read in her LinkedIn profile, but I’ve a feeling if I’d clicked that ‘More’ button, there would be a lot more. Welcome to the show, amazing Hilary Mason! Hilary Mason: Thank you very much. Thank you for having me. I always like to start with...
Post a Comment
Read more